Hospital Pharmacy presents this new feature to keep pharmacists abreast of new publications in the medical/pharmacy literature. Articles of interest will be abstracted monthly regarding a broad scope of topics.
Get full access to this article
View all access options for this article.
References
1.
TitchenT., CranswickN., BeggsS.Adverse drug reactions to nonsteroidal anti-inflammatory drugs, COX-2 inhibitors and paracetamol in a pediatric hospital.Br J Clin Pharm.2005; 59(6): 718–723.
2.
CookN.R., LeeI.M., GazianoM.Low dose aspirin in the primary prevention of cancer: the Women's Health Study: A randomized controlled trial.JAMA.2005; 294(1): 47–55.
3.
LeeI.M., CookN.R., GazianoM.Vitamin E in the primary prevention of cardiovascular disease and cancer: the Wo men's Health Study: a randomized controlled trial.JAMA.2005; 294(1): 56–65.
4.
PatoleS., RaoS., DohertyS.Erythromycin as a prokinetic agent in preterm neonates: a systematic review.Arch Dis Child Fetal Neonatal Ed.2005; 90: F301–F306.
5.
TefferiA., HansonC.A., InwardsD.J.How to interpret and pursue an abnormal complete blood cell count in adults.Mayo Clin Proc.2005; 80(7): 923–936.
6.
IngelssonE., SundstromJ., ArnlovJ.Insulin resistance and risk of congestive heart failure.JAMA.2005; 294: 334–341.
7.
MaloneM., Alger-MayerS.A., AndersonD.A.Medication associated with weight gain may influence outcome in a weight management program.Annals of Pharmacother.2005; 39: 1204–1208.
8.
ChhabraR., KremznerM.E., KilianyB.J.FDA policy on unapproved drug products: Past, present, and future.Pharmacother.2005; 39: 1260–1264.
9.
GrauA.J., FischerB., BarthC.Influenza vaccination is associated with a reduced risk of stroke.Stroke.2005; 26: 1501–1506.
WasleyA., SamandariT., BellB.P.Incidence of hepatitis A in the United States in the era of vaccination.JAMA.2005; 294: 194–201.
12.
OckeneJ.K., BaradD.H., CochraneB.B.Symptom experience after discontinuing use of estrogen plus progestin.JAMA.2005; 294: 183–193.
13.
DoddM.L., KlosK.J., BowenJ.H.Pathological gambling caused by drugs used to treat Parkinson's disease.Arch Neurology.2005; 62: 1–5.
14.
BurtonE.C., BurnsD.K., OpatowskyM.J.Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients.Arch Neurol.2005; 62: 873–882.
15.
RoosK.L.Fatal encephalitis due to rabies virus transmitted by organ transplantation.Arch Neurology.2005; 62: 855–856.
16.
TaylorC.B., YoungbloodM.E., CatellierD.Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction.Arch Gen Psychiatry.2005; 62: 792–798.
17.
RitzM.A., ChapmanM.J., FraserR.B.Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill.Intensive Care Med.2005; 31: 949–954.
18.
ChenK., ChengE.Y., SummersK.H.Comparison of costs and utilization between users of insulin lispro versus users of regular insulin in a managed care setting.J Manag Care Pharm.2005; 11: 376–382.
19.
MullinsC.D., WeisK.A., PerfettoE.M.Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat.J Manag Care Pharm.2005; 11: 394–402.
20.
ManserT., StaenderS.Aftermath of an adverse event: supporting health care professionals to meet patient expectations through open disclosure.Acta Anaesthesiol Scand.2005; 49: 728–754.
21.
Al-TajirG.K., KellyW.N.Epidemiology, comparative methods of detection, and preventability of adverse drug events.Ann Pharmacother.2005; 39: 1169–1174.
22.
EvansR.S., LloydJ.F., StoddardG.J.Risk factors for adverse drug events: a 10-year analysis.Annals Pharmacotherapy.2005; 39: 1161–1168.
23.
BenahmedS., PicotM.C., DumasF.Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions.Arch Intern Med.2005; 165: 1500–1505.
24.
MarchettiF., RonfaniL., NibaltS.C.Delayed prescription may reduce the use of antibiotics for acute otitis media.Arch Pediatr Adolesc Med.2005; 159: 679–684.
25.
FordE.S., AjaniU.A., MokdadA.H.Brief communication: The prevalence of high intake of vitamin E from the use of supplements among US adults.Ann Intern Med.2005; 143: 116–120.
26.
KastangoE.S.Blueprint for implementing USP chapter 797 for compounding sterile preparations.Am J Health System Pharm.2005; 62: 1271–1288.
